Genetic Technologies Executes Covenant Not to Sue And Release Agreement with One Lambda
In compliance with ASX Continuous Disclosure Rules, Genetic Technologies Limited (NASDAQ: GENE) is pleased to report it has executed a Covenant Not To Sue And Release Agreement with One Lambda Inc. (“One Lambda”) of Canoga Park, California, USA. The precise commercial terms of the Agreement are covered by formal confidentiality provisions and cannot be disclosed. The agreement was reached as a result of GTG's continuing patent monetization efforts in the US and other jurisdictions.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.